Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $826.45 billion, total revenue of $173 billion and a weighted average PE ratio of 46.03.
Market Cap
826.45B
Revenue
173B
Profits
17.95B
PE Ratio
46.03
Profit Margin
10.38%
Dividend Yield
0.20%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 222.37B | -0.60% | 750,474 | 46.34B |
| 2 | DHR | Danaher Corporation | 145.78B | -0.03% | 1,449,314 | 25.11B |
| 3 | NTRA | Natera, Inc. | 45.25B | 0.38% | 439,948 | 2.71B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 45.07B | -2.48% | 217,133 | 4.55B |
| 5 | A | Agilent Technologies, Inc. | 41.90B | -0.77% | 559,760 | 7.23B |
| 6 | WAT | Waters Corporation | 40.79B | 0.05% | 331,571 | 4.64B |
| 7 | IQV | IQVIA Holdings Inc. | 40.04B | -0.23% | 366,592 | 16.98B |
| 8 | ILMN | Illumina, Inc. | 28.94B | -0.62% | 585,165 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 28.70B | -0.35% | 64,012 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 26.22B | 0.03% | 289,968 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 26.12B | -0.11% | 170,191 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 22.07B | -0.39% | 632,959 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.77B | -0.78% | 127,950 | 2.78B |
| 14 | CRL | Charles River Laboratories International, Inc. | 13.72B | 1.90% | 504,346 | 4.00B |
| 15 | RVTY | Revvity, Inc. | 12.95B | 0.29% | 394,874 | 2.91B |
| 16 | ICLR | ICON Public Limited Company | 12.89B | 0.91% | 289,922 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 8.89B | 0.82% | 1,734,236 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 7.77B | 0.59% | 754,165 | 431.80M |
| 19 | RDNT | RadNet, Inc. | 6.03B | 0.37% | 278,296 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.39B | -1.20% | 600,959 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.61B | -0.27% | 315,554 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 3.98B | -1.73% | 570,124 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.65B | -2.24% | 266,601 | 561.90M |
| 24 | GRAL | GRAIL, Inc. | 3.17B | -6.08% | 237,262 | 165.26M |
| 25 | WGS | GeneDx Holdings Corp. | 2.45B | 0.34% | 251,071 | 454.43M |
| 26 | CDNA | CareDx, Inc. | 2.44B | -0.15% | 328,888 | 458.09M |
| 27 | NEO | NeoGenomics, Inc. | 2.10B | -1.03% | 458,388 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.51B | 1.07% | 1,008,225 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.31B | -3.25% | 927,972 | 34.24M |
| 30 | OPK | OPKO Health, Inc. | 1.04B | 0.01% | 846,855 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 966.28M | -1.89% | 136,191 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 515.36M | -1.42% | 59,561 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 302.73M | -1.71% | 395,977 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 258.08M | 0.62% | 70,443 | 102.94M |
| 35 | XGN | Exagen Inc. | 161.34M | -1.62% | 123,943 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 139.82M | -2.26% | 208,703 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 110.55M | -4.01% | 454,227 | 537.08K |
| 38 | BNR | Burning Rock Biotech Limited | 104.51M | -4.91% | 773 | 74.58M |
| 39 | PRPO | Precipio, Inc. | 39.47M | -1.19% | 69,030 | 25.83M |
| 40 | MDXH | MDxHealth SA | 23.52M | 3.83% | 314,884 | 110.97M |
| 41 | ADVB | Advanced Biomed Inc. | 12.32M | -3.99% | 602,250 | - |
| 42 | MBAI | Check-Cap Ltd. | 9.89M | 7.11% | 110,121 | - |
| 43 | XWEL | XWELL, Inc. | 8.49M | 1.56% | 20,659 | 28.83M |
| 44 | NDRA | ENDRA Life Sciences Inc. | 5.61M | 0.23% | 1,491 | - |
| 45 | ISPC | iSpecimen Inc. | 5.57M | 0.44% | 33,914 | 1.03M |
| 46 | BIAF | bioAffinity Technologies, Inc. | 2.15M | -2.16% | 38,144 | 5.90M |